Last Updated: June 30, 2026

Claims for Patent: 8,192,747

✉ Email this page to a colleague

Summary for Patent: 8,192,747

Title:	Live attenuated rotavirus vaccine for oral administration
Abstract:	This invention provides liquid rotavirus formulations that are suitable for oral administration to human infants. In particular, the invention provides pharmaceutical compositions and vaccines, comprising a rotavirus antigen, a sugar and a carboxylate, wherein said formulation has a pH of between pH 5.0 and pH 8.0 and comprises no phosphate or less than 5 mM phosphate. The invention also provides methods of preparing said rotavirus formulations and use thereof in the prevention or treatment or rotavirus associated diseases in humans.
Inventor(s):	Vincent Vande Velde
Assignee:	GlaxoSmithKline Biologicals SA
Application Number:	US11/816,443

Details for Patent 8,192,747

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Glaxosmithkline Biologicals	ROTARIX	rotavirus vaccine, live, oral	For Suspension	125265	April 03, 2008	8,192,747	2026-02-15
Glaxosmithkline Biologicals	ROTARIX	rotavirus vaccine, live, oral	Suspension	125265	November 04, 2022	8,192,747	2026-02-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,192,747

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
African Regional IP Organization (ARIPO)	2692	⤷ Start Trial
Argentina	053680	⤷ Start Trial
Austria	E516044	⤷ Start Trial
Australia	2006215761	⤷ Start Trial
Brazil	PI0608877	⤷ Start Trial
Canada	2598290	⤷ Start Trial
China	101300028	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.